Update shared on 16 Dec 2025
Fair value Decreased 0.32%Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple.
What's in the News
- Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology. (Key Developments)
- The company maintained fiscal 2026 guidance, expecting all in sales growth of 1% to 5%, organic sales growth of in line to up 4%, and diluted EPS growth of 3% to 9% versus fiscal 2025. (Key Developments)
- P&G completed a buyback tranche, repurchasing 8,024,225 shares, or 0.34% of shares outstanding, for approximately $1.25 billion under the July 29, 2025 authorization. (Key Developments)
- Tide introduced its largest upgrade to Original Liquid Detergent in over 20 years, boosting cleaning surfactants and adding new polymer technology for stronger stain removal, better whiteness, and longer lasting freshness without raising price. (Key Developments)
- P&G brands Gain, Febreze, and Dawn launched limited edition Wicked: For Good collections with new Gain based fragrances tied to the upcoming film release, available at major retailers nationwide. (Key Developments)
Valuation Changes
- The fair value estimate has fallen slightly to approximately $168.50 from about $169.05 per share.
- The discount rate is effectively unchanged, edging down marginally from about 6.96% to 6.96%.
- The revenue growth assumption has decreased slightly from roughly 3.19% to about 3.15% per year.
- The net profit margin assumption has risen modestly from around 19.59% to approximately 19.61%.
- The future P/E multiple has been trimmed slightly from about 26.16x to roughly 26.07x expected earnings.
Have other thoughts on Procter & Gamble?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.